Niels Bergsland1, Michael G. Dwyer1,
Dana Horakova2, Ondrej Dolezal1, Zdenek Seidl3,
Manuela Vaneckova3, Eva Havrdova2, Robert Zivadinov4
1University at Buffalo, Buffalo
Neuroimaging Analysis Center, Buffalo, NY, United States; 2Charles
University, Department of Neurology, Prague, Czech Republic; 3Charles
University, Department of Radiology, Prague, Czech Republic; 4Neurology,
Buffalo Neuroimaging Analysis Center, Buffalo , NY , United States
To
quantify deep gray matter (DGM) atrophy in a large sample of clinically
isolated syndrome (CIS) patients, early relapsing-remitting (RR) multiple
sclerosis (MS) patients, and healthy controls (HC). To investigate the
relationship between DGM atrophy and disability in CIS patients.